Lowering Mutant Huntingtin Levels and Toxicity: Autophagy-Endolysosome Pathways in Huntington's Disease

被引：31
|
作者：
Valionyte, Evelina [1 ,2 ]
Yang, Yi [1 ,2 ]
Roberts, Sheridan L. [1 ,2 ]
Kelly, Jack [1 ,2 ]
Lu, Boxun [3 ]
Luo, Shouqing [1 ,2 ]
机构：
[1] Univ Plymouth, Peninsula Sch Med, Inst Translat & Stratified Med, Res Way, Plymouth PL6 8BU, Devon, England
[2] Univ Plymouth, Peninsula Sch Dent, Inst Translat & Stratified Med, Res Way, Plymouth PL6 8BU, Devon, England
[3] Fudan Univ, Collaborat Innovat Ctr Brain Sci, Sch Life Sci, State Key Lab Med Neurobiol, Shanghai 200438, Peoples R China
来源：
JOURNAL OF MOLECULAR BIOLOGY | 2020年 / 432卷 / 08期
基金：
中国国家自然科学基金; 英国医学研究理事会;
关键词：
Autophagy; Selective autophagy; Huntington's disease; Huntingtin; Neu rodegeneration; INCLUSION-BODY FORMATION; SELECTIVE AUTOPHAGY; MOUSE MODEL; POLYGLUTAMINE EXPANSIONS; MOLECULAR-MECHANISMS; TRINUCLEOTIDE REPEAT; ACTIVATES AUTOPHAGY; RECEPTOR OPTINEURIN; MEDIATED AUTOPHAGY; NUCLEAR INCLUSIONS;
D O I：
10.1016/j.jmb.2019.11.012
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Huntington's disease (HD) is a monogenetic neurodegenerative disease, which serves as a model of neurodegeneration with protein aggregation. Autophagy has been suggested to possess a great value to tackle protein aggregation toxicity and neurodegenerative diseases. Current studies suggest that autophagyendolysosomal pathways are critical for HD pathology. Here we review recent advancement in the studies of autophagy and selective autophagy relating HD. Restoration of autophagy flux and enhancement of selective removal of mutant huntingtin/disease-causing protein would be effective approaches towards tackling HD as well as other similar neurodegenerative disorders. (C) 2019 Elsevier Ltd. All rights reserved.
引用
收藏
页码：2673 / 2691
页数：19
相关论文
共 50 条
  • [31] Huntington's disease cerebrospinal fluid seeds aggregation of mutant huntingtin
    Tan, Z.
    Dai, W.
    van Erp, T. G. M.
    Overman, J.
    Demuro, A.
    Digman, M. A.
    Hatami, A.
    Albay, R.
    Sontag, E. M.
    Potkin, K. T.
    Ling, S.
    Macciardi, F.
    Bunney, W. E.
    Long, J. D.
    Paulsen, J. S.
    Ringman, J. M.
    Parker, I.
    Glabe, C.
    Thompson, L. M.
    Chiu, W.
    Potkin, S. G.
    MOLECULAR PSYCHIATRY, 2015, 20 (11) : 1286 - 1293
  • [32] Mutant Huntingtin Protein Interaction Map Implicates Dysregulation of Multiple Cellular Pathways in Neurodegeneration of Huntington's Disease
    Podvin, Sonia
    Rosenthal, Sara Brin
    Poon, William
    Wei, Enlin
    Fisch, Kathleen M.
    Hook, Vivian
    JOURNAL OF HUNTINGTONS DISEASE, 2022, 11 (03) : 243 - 267
  • [33] TBK1 phosphorylates mutant Huntingtin and suppresses its aggregation and toxicity in Huntington's disease models
    Hegde, Ramanath Narayana
    Chiki, Anass
    Petricca, Lara
    Martufi, Paola
    Arbez, Nicolas
    Mouchiroud, Laurent
    Auwerx, Johan
    Landles, Christian
    Bates, Gillian P.
    Singh-Bains, Malvindar K.
    Dragunow, Mike
    Curtis, Maurice A.
    Faull, Richard L. M.
    Ross, Christopher A.
    Caricasole, Andrea
    Lashuel, Hilal A.
    EMBO JOURNAL, 2020, 39 (17):
  • [34] Matrix Metalloproteinases Are Modifiers of Huntingtin Proteolysis and Toxicity in Huntington's Disease
    Miller, John P.
    Holcomb, Jennifer
    Al-Ramahi, Ismael
    de Haro, Maria
    Gafni, Juliette
    Zhang, Ningzhe
    Kim, Eugene
    Sanhueza, Mario
    Torcassi, Cameron
    Kwak, Seung
    Botas, Juan
    Hughes, Robert E.
    Ellerby, Lisa M.
    NEURON, 2010, 67 (02) : 199 - 212
  • [35] High Levels of Mutant Huntingtin Protein in Tear Fluid From Huntington's Disease Gene Expansion Carriers
    Gijs, Marlies
    Jorna, Nynke
    Datson, Nicole
    Beekman, Chantal
    Dansokho, Cira
    Weiss, Alexander
    Linden, David E. J.
    Oosterloo, Mayke
    JOURNAL OF MOVEMENT DISORDERS, 2024, 17 (02) : 181 - 188
  • [36] Mutant Huntingtin Derails Cysteine Metabolism in Huntington's Disease at Both Transcriptional and Post-Translational Levels
    Paul, Bindu D.
    Sbodio, Juan I.
    Snyder, Solomon H.
    ANTIOXIDANTS, 2022, 11 (08)
  • [37] Embryonic Mutant Huntingtin Aggregate Formation in Mouse Models of Huntington's Disease
    Osmand, Alexander P.
    Bichell, Terry Jo.
    Bowman, Aaron B.
    Bates, Gillian P.
    JOURNAL OF HUNTINGTONS DISEASE, 2016, 5 (04) : 343 - 346
  • [38] Analysis of mutant and total huntingtin expression in Huntington's disease murine models
    Fodale, Valentina
    Pintauro, Roberta
    Daldin, Manuel
    Altobelli, Roberta
    Spiezia, Maria Carolina
    Bisbocci, Monica
    Macdonald, Douglas
    Bresciani, Alberto
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [39] Allele-Specific Silencing of Mutant Huntingtin for Huntington's Disease Therapy
    Mas-Monteys, Alex
    Harper, Scott Q.
    Gilmore, Brian L.
    Staber, Patrick D.
    Schaffer, Chris
    Polisky, Barry
    Vargeese, Chandra
    Davidson, Beverly L.
    MOLECULAR THERAPY, 2006, 13 : S274 - S275
  • [40] Mutant huntingtin fragmentation in immune cells tracks Huntington's disease progression
    Weiss, Andreas
    Traeger, Ulrike
    Wild, Edward J.
    Grueninger, Stephan
    Farmer, Ruth
    Landles, Christian
    Scahil, Rachael I.
    Lahiri, Nayana
    Haider, Salman
    Macdonald, Douglas
    Frost, Chris
    Bates, Gillian P.
    Bilbe, Graeme
    Kuhn, Rainer
    Andre, Ralph
    Tabrizi, Sarah J.
    JOURNAL OF CLINICAL INVESTIGATION, 2012, 122 (10): : 3731 - 3736
12345